Covid-19 roundup: Bay­er ex­pands deal with Cure­Vac to pro­duce shots; UK or­ders more Val­ne­va vac­cines

Fol­low­ing the part­ner­ships among Sanofi and No­var­tis to up­scale the Pfiz­er/BioN­Tech Covid-19 vac­cine, an­oth­er Big Phar­ma is step­ping in to help vac­cine pro­duc­tion.

Bay­er has agreed to pro­duce Cure­Vac’s Covid-19 jabs, the com­pa­nies an­nounced Mon­day, as sup­ply con­tin­ues to lag around the world. Though Bay­er won’t start pro­duc­ing the vac­cine un­til the end of 2021, the move ex­pands the col­lab­o­ra­tion be­tween the com­pa­nies that had al­lowed for Bay­er to as­sist Cure­Vac in ob­tain­ing reg­u­la­to­ry clear­ances and in dis­tri­b­u­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER